FDA | What's New
Follow
Public Meeting on the Recommendations for Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 09/16/2026
The Food and Drug Administration is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032.